Achilles Therapeutics plc / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €4.04M
    Gross profit
    -€4.04M
    SG&A expenses
    €12.03M
    R&D expenses
    €46.77M
    EBITDA
    -€56.54M
    D&A
    €4.04M
    EBIT
    -€60.81M
    Interest expenses
    €0.00
    EBT
    -€54.61M
    Tax expenses
    €403.61K
    Net income
    -€55.02M

    Cash flow statement

    Net deferred tax
    -€5.24M
    Non-cash items
    -€7.17M
    Changes in working capital
    €7.80M
    Operating cash flow
    -€26.31M
    Capex
    €687.80K
    Other investing cash flow
    -€30.86K
    Net investing cash flow
    -€718.66K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €11.18K
    Debt repayment
    €0.00
    Other financing cash flow
    €2.45
    Net financing cash flow
    €11.18K
    Foreign exchange effects
    €3.96M
    Net change in cash
    -€41.68M
    Cash at end of period
    €81.65K
    Free cash flow
    -€25.62M

    Balance sheet

    Cash and cash equivalents
    €81.61M
    Cash and short-term investments
    €81.61M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €19.48M
    Total current assets
    €101.09M
    Property, plant & equipment
    €9.54M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €45.47K
    Other non-current assets
    €1.89M
    Total non-current assets
    €11.47M
    Total assets
    €112.56M
    Accounts payable
    €2.46M
    Short-term debt
    €3.61M
    Other current liabilities
    €6.20M
    Total current liabilities
    €12.27M
    Long-term debt
    €221.36K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €993.56K
    Total non-current liabilities
    €1.21M
    Total liabilities
    €13.48M
    Common stock
    €156.16K
    Retained earnings
    -€247.62M
    Other equity
    -€12.02M
    Total equity
    €99.08M
    Total liabilities and shareholders' equity
    €112.56M

    Company information

    Market capitalization
    €51.88M
    Employees
    204
    Enterprise Value
    -€21.60M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -55.5% Much better than peer group: -104.5%
    ROA
    -48.9% Better than peer group: -54.1%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -52.0%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€269.69K

    Notifications